San Diego Fertility Center, Medical Group IncMay 26, 2023

FDA 483 - San Diego Fertility Center, Medical Group Inc - May 26, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore San Diego Fertility Center, Medical Group Inc

Record Details

An FDA inspection of San Diego Fertility Center, Medical Group, Inc, a human reproductive tissue establishment, identified a significant deficiency in donor screening practices. The firm failed to adequately screen donors for communicable disease agents and diseases. This included missing critical risk factors for West Nile Virus, HIV group O, and xenotransplantation exposure on their donor medical history questionnaire.

Company: San Diego Fertility Center, Medical Group Inc
Inspection Date: May 26, 2023
Product Type: Biologics
Office: Division of Pharmaceutical Quality Operations IV
Person: Paul M. Chefor (Investigator)

Open in Dashboard

ID · 8d24f032-011a-4f3d-be87-2f4589ab198c